Latest California Healthline Stories
Dialysis companies have contributed more than $104 million to defeat an initiative on California’s Nov. 6 ballot that would limit their profits — and are on the cusp of breaking the $109 million record set by the pharmaceutical industry in 2016.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicare’s annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.
Nearly three-quarters of voters say that health care is the most important issue for them, but fewer than half are hearing much from candidates about it, according to a poll released by the Kaiser Family Foundation.
Drugmakers’ contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, members of Congress have received nearly $79 million from 68 pharma PACs. And the giving crosses the aisle: In California, seven of the top 10 beneficiaries are Democrats — though Kevin McCarthy, the Republican House majority leader, tops other Golden State lawmakers in Congress by a wide margin.
Drug pricing is a top issue in the run-up to the midterm elections.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
California’s 13 children’s hospitals are asking voters in November to approve $1.5 billion in bonds to help them pay for construction and equipment, the third such measure in 14 years. Some health care experts and election analysts believe the repeated financial requests aren’t justified.
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the Trump administration’s announcement that average premium prices are falling on the Obamacare marketplaces, the effort by Senate Democrats to reverse rules on short-term health insurance and the focus on protections for people with preexisting conditions in the run-up to midterm elections.
The Trump administration announces that the average price for insurance offered to people buying their own coverage on federal exchanges is going down.
Consumers favor ACA’s safeguards on the promise that patients who have health problems can get insurance. In the heat of the midterm campaigns, politicians in both parties agree, but their arguments don’t always add up.